In Utero Exposure to Mercury Is Associated With Increased Susceptibility to Liver Injury and Inflammation in Childhood.


Journal

Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946

Informations de publication

Date de publication:
09 2021
Historique:
revised: 21 01 2021
received: 26 10 2020
accepted: 23 02 2021
pubmed: 18 3 2021
medline: 13 1 2022
entrez: 17 3 2021
Statut: ppublish

Résumé

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent cause of liver disease in children. Mercury (Hg), a ubiquitous toxic metal, has been proposed as an environmental factor contributing to toxicant-associated fatty liver disease. We investigated the effect of prenatal exposure to Hg on childhood liver injury by combining epidemiological results from a multicenter mother-child cohort with complementary in vitro experiments on monocyte cells that are known to play a key role in liver immune homeostasis and NAFLD. We used data from 872 mothers and their children (median age, 8.1 years; interquartile range [IQR], 6.5-8.7) from the European Human Early-Life Exposome cohort. We measured Hg concentration in maternal blood during pregnancy (median, 2.0 μg/L; IQR, 1.1-3.6). We also assessed serum levels of alanine aminotransferase (ALT), a common screening tool for pediatric NAFLD, and plasma concentrations of inflammation-related cytokines in children. We found that prenatal Hg exposure was associated with a phenotype in children that was characterized by elevated ALT (≥22.1 U/L for females and ≥25.8 U/L for males) and increased concentrations of circulating IL-1β, IL-6, IL-8, and TNF-α. Consistently, inflammatory monocytes exposed in vitro to a physiologically relevant dose of Hg demonstrated significant up-regulation of genes encoding these four cytokines and increased concentrations of IL-8 and TNF-α in the supernatants. These findings suggest that developmental exposure to Hg can contribute to inflammation and increased NAFLD risk in early life.

Sections du résumé

BACKGROUND AND AIMS
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent cause of liver disease in children. Mercury (Hg), a ubiquitous toxic metal, has been proposed as an environmental factor contributing to toxicant-associated fatty liver disease.
APPROACH AND RESULTS
We investigated the effect of prenatal exposure to Hg on childhood liver injury by combining epidemiological results from a multicenter mother-child cohort with complementary in vitro experiments on monocyte cells that are known to play a key role in liver immune homeostasis and NAFLD. We used data from 872 mothers and their children (median age, 8.1 years; interquartile range [IQR], 6.5-8.7) from the European Human Early-Life Exposome cohort. We measured Hg concentration in maternal blood during pregnancy (median, 2.0 μg/L; IQR, 1.1-3.6). We also assessed serum levels of alanine aminotransferase (ALT), a common screening tool for pediatric NAFLD, and plasma concentrations of inflammation-related cytokines in children. We found that prenatal Hg exposure was associated with a phenotype in children that was characterized by elevated ALT (≥22.1 U/L for females and ≥25.8 U/L for males) and increased concentrations of circulating IL-1β, IL-6, IL-8, and TNF-α. Consistently, inflammatory monocytes exposed in vitro to a physiologically relevant dose of Hg demonstrated significant up-regulation of genes encoding these four cytokines and increased concentrations of IL-8 and TNF-α in the supernatants.
CONCLUSIONS
These findings suggest that developmental exposure to Hg can contribute to inflammation and increased NAFLD risk in early life.

Identifiants

pubmed: 33730435
doi: 10.1002/hep.31809
pmc: PMC8446089
mid: NIHMS1708913
doi:

Substances chimiques

CXCL8 protein, human 0
Cytokines 0
IL1B protein, human 0
IL6 protein, human 0
Interleukin-1beta 0
Interleukin-6 0
Interleukin-8 0
TNF protein, human 0
Tumor Necrosis Factor-alpha 0
Alanine Transaminase EC 2.6.1.2
Mercury FXS1BY2PGL

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1546-1559

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK106491
Pays : United States
Organisme : NIEHS NIH HHS
ID : R21 ES029681
Pays : United States
Organisme : NIEHS NIH HHS
ID : P01 ES022845
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES030691
Pays : United States
Organisme : NIEHS NIH HHS
ID : R21 ES028903
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA140561
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK117004
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES030364
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK048522
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P01 CA196569
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES029944
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES007048
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 by the American Association for the Study of Liver Diseases.

Références

Toxicol Sci. 2014 Dec;142(2):339-49
pubmed: 25237059
Lancet Diabetes Endocrinol. 2019 Apr;7(4):313-324
pubmed: 30174213
Hepatol Commun. 2018 Sep 21;2(11):1344-1355
pubmed: 30411081
Int J Mol Sci. 2020 Jun 11;21(11):
pubmed: 32545403
Environ Health Perspect. 2009 Jan;117(1):47-53
pubmed: 19165386
Environ Sci Pollut Res Int. 2019 Oct;26(30):31384-31391
pubmed: 31473923
Nat Rev Gastroenterol Hepatol. 2017 Feb;14(2):81-96
pubmed: 27780972
Gut. 2017 May;66(5):930-938
pubmed: 26858343
Chemosphere. 2018 Jul;202:330-338
pubmed: 29574386
Toxicol Lett. 2010 Dec 15;199(3):225-33
pubmed: 20837117
Hepatology. 2016 Mar;63(3):745-53
pubmed: 26638195
Hepatology. 2018 Jan;67(1):123-133
pubmed: 28802062
Environ Res. 2014 Apr;130:14-9
pubmed: 24525240
J Dev Orig Health Dis. 2014 Feb;5(1):16-30
pubmed: 24847687
Environ Int. 2019 Mar;124:278-283
pubmed: 30660840
Cell. 2018 Nov 29;175(6):1607-1619.e15
pubmed: 30500539
Hepatol Commun. 2020 Jan 14;4(4):478-492
pubmed: 32258944
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):319-334
pubmed: 28107283
Gastroenterology. 2010 Jul;139(1):323-34.e7
pubmed: 20347818
PLoS One. 2009 Nov 20;4(11):e7929
pubmed: 19936233
Environ Sci Pollut Res Int. 2020 Feb;27(6):6476-6487
pubmed: 31873887
Environ Int. 2018 Dec;121(Pt 1):751-763
pubmed: 30326459
Cell Death Dis. 2020 Mar 31;11(3):212
pubmed: 32235829
J Prev Med Public Health. 2017 Nov;50(6):377-385
pubmed: 29207447
Hepatol Commun. 2017 Sep;1(7):609-622
pubmed: 29130075
Metabolism. 2016 Aug;65(8):1062-79
pubmed: 26725002
Cytokine. 2019 Dec;124:154519
pubmed: 30139548
Environ Sci Technol. 2013 May 21;47(10):4967-83
pubmed: 23590191
Bioinformatics. 2020 Feb 1;36(3):842-850
pubmed: 31504184
Int J Toxicol. 2009 Jul-Aug;28(4):294-307
pubmed: 19636072
BMJ Open. 2018 Sep 10;8(9):e021311
pubmed: 30206078
Bull World Health Organ. 2007 Sep;85(9):660-7
pubmed: 18026621
Environ Health Perspect. 2010 Dec;118(12):1735-42
pubmed: 21126940
World J Gastroenterol. 2012 Feb 28;18(8):727-35
pubmed: 22371632
Int J Epidemiol. 2016 Apr;45(2):382-8
pubmed: 27063603
J Clin Endocrinol Metab. 2019 Jan 1;104(1):21-37
pubmed: 30137403
Environ Res. 2010 May;110(4):345-54
pubmed: 20176347
PLoS One. 2015 Oct 29;10(10):e0140908
pubmed: 26512983
Adv Exp Med Biol. 2018;1061:45-53
pubmed: 29956205
Gastroenterology. 2015 Sep;149(3):635-48.e14
pubmed: 26028579
Environ Health Perspect. 2011 Dec;119(12):1733-8
pubmed: 21868305
Am J Gastroenterol. 2008 Jun;103(6):1372-9
pubmed: 18510618
Nat Rev Endocrinol. 2017 Aug;13(8):445-457
pubmed: 28524171
J Trace Elem Med Biol. 2019 Dec;56:60-68
pubmed: 31442956
Hepatology. 2018 Apr;67(4):1270-1283
pubmed: 28940700
JAMA Netw Open. 2020 Mar 2;3(3):e201007
pubmed: 32176304
Toxicol Pathol. 2013 Feb;41(2):343-60
pubmed: 23262638
Environ Res. 2014 Nov;135:63-9
pubmed: 25262076
Hepatology. 2017 Jan;65(1):65-77
pubmed: 27532276
Hepatology. 2019 Jul;70(1):67-83
pubmed: 30516830

Auteurs

Nikos Stratakis (N)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Lucy Golden-Mason (L)

Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Katerina Margetaki (K)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Yinqi Zhao (Y)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Damaskini Valvi (D)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY.

Erika Garcia (E)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Léa Maitre (L)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.

Sandra Andrusaityte (S)

Department of Environmental Sciences, Vytautas Magnus University, Kaunas, Lithuania.

Xavier Basagana (X)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.

Eva Borràs (E)

Universitat Pompeu Fabra, Barcelona, Spain.
Proteomics Unit, Centre de Regulació Genòmica, Barcelona Institute of Science and Technology, Barcelona, Spain.

Mariona Bustamante (M)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.

Maribel Casas (M)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.

Serena Fossati (S)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.

Regina Grazuleviciene (R)

Department of Environmental Sciences, Vytautas Magnus University, Kaunas, Lithuania.

Line Småstuen Haug (LS)

Norwegian Institute of Public Health, Oslo, Norway.

Barbara Heude (B)

Centre for Research in Epidemiology and Statistics, Université de Paris, INSERM, INRAE, Paris, France.

Rosemary R C McEachan (RRC)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.

Helle Margrete Meltzer (HM)

Norwegian Institute of Public Health, Oslo, Norway.

Eleni Papadopoulou (E)

Norwegian Institute of Public Health, Oslo, Norway.

Theano Roumeliotaki (T)

Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Crete, Greece.

Oliver Robinson (O)

MRC Centre for Environment and Health, Imperial College London, London, UK.

Eduard Sabidó (E)

Universitat Pompeu Fabra, Barcelona, Spain.
Proteomics Unit, Centre de Regulació Genòmica, Barcelona Institute of Science and Technology, Barcelona, Spain.

Jose Urquiza (J)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.

Marina Vafeiadi (M)

Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Crete, Greece.

Nerea Varo (N)

Laboratorio de Bioquímica, Clínica Universidad de Navarra, Pamplona, Spain.

John Wright (J)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.

Miriam B Vos (MB)

Department of Pediatrics, School of Medicine and Nutrition Health Sciences, Emory University, Atlanta, GA.
Children's Healthcare of Atlanta, Atlanta, GA.

Howard Hu (H)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Martine Vrijheid (M)

ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.

Kiros T Berhane (KT)

Mailman School of Public Health, Columbia University, New York, NY.

David V Conti (DV)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Rob McConnell (R)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Hugo R Rosen (HR)

Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Lida Chatzi (L)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH